Gelteq Ltd SEC filings GELS
Gelteq Ltd has 72 filings in SEC EDGAR's recent list, going back to Mar 31, 2022. Its latest annual report, Form 20-F, was filed on Nov 17, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Jul 6, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 2, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | May 26, 2026 | May 26, 2026 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
| 6-K | Current report (foreign issuer) | Dec 9, 2025 | Dec 9, 2025 |
| 6-K | Current report (foreign issuer) | Jun 30, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 14, 2025 | Mar 14, 2025 |
| 6-K | Current report (foreign issuer) | Oct 30, 2024 | Oct 30, 2024 |
Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GELS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- South Melbourne Vic
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1920092
- Former names
- Gelteq Pty Ltd. (until Mar 31, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.